These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 8668612)

  • 41. Effect of Eclipta prostrata on lipid metabolism in hyperlipidemic animals.
    Zhao Y; Peng L; Lu W; Wang Y; Huang X; Gong C; He L; Hong J; Wu S; Jin X
    Exp Gerontol; 2015 Feb; 62():37-44. PubMed ID: 25562812
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A symposium: lipid management summit on improving practice outcome. Introduction.
    Ballantyne CM
    Am J Cardiol; 2000 Feb; 85(3A):1A-2A. PubMed ID: 10695700
    [No Abstract]   [Full Text] [Related]  

  • 43. [Niacin--an additive therapeutic approach for optimizing lipid profile].
    Wieneke H; Schmermund A; Erbel R
    Med Klin (Munich); 2005 Apr; 100(4):186-92. PubMed ID: 15834527
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The CEPHEUS Pan-Asian survey: high low-density lipoprotein cholesterol goal attainment rate among hypercholesterolaemic patients undergoing lipid-lowering treatment in a Hong Kong regional centre.
    Chan RH; Chan PH; Chan KK; Lam SC; Hai JJ; Wong MK; Tam FC; Lam L; Chan CW; Lam YM; Siu DC; Tse HF; Lee SW
    Hong Kong Med J; 2012 Oct; 18(5):395-406. PubMed ID: 23018067
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A long-term follow-up study of serum lipid levels and coronary heart disease in the elderly.
    Li JZ; Chen ML; Wang S; Dong J; Zeng P; Hou LW
    Chin Med J (Engl); 2004 Feb; 117(2):163-7. PubMed ID: 14975195
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Pharmacologic treatment of type 2 diabetic dyslipidemia.
    Moon YS; Kashyap ML
    Pharmacotherapy; 2004 Dec; 24(12):1692-713. PubMed ID: 15585439
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The emerging role of HDL cholesterol. Is it time to focus more energy on raising high-density lipoprotein levels?
    Safeer RS; Cornell MO
    Postgrad Med; 2000 Dec; 108(7):87-90, 93-8. PubMed ID: 11126145
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Attainment of normal lipid levels among patients on lipid-modifying therapy in Hong Kong.
    Ambegaonkar B; Chirovsky D; Tse HF; Lau YK; Tomlinson B; Li SK; Yue CS; Wong TH; Choi MC; Tunggal P; Sazonov V
    Adv Ther; 2012 May; 29(5):427-41. PubMed ID: 22562782
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The hypolipidemic activity of novel benzofuran-2-carboxamide derivatives in Triton WR-1339-induced hyperlipidemic rats: a comparison with bezafibrate.
    Shattat G; Al-Qirim T; Sweidan K; Shahwan M; El-Huneidi W; Al-Hiari Y
    J Enzyme Inhib Med Chem; 2010 Dec; 25(6):751-5. PubMed ID: 20590406
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Treatment of hyperlipidemia in HIV-infected patients.
    Geletko SM; ZuWallack AR
    Am J Health Syst Pharm; 2001 Apr; 58(7):607-14. PubMed ID: 11296612
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Optimal management of cholesterol levels and the prevention of coronary heart disease in women.
    Mosca LJ
    Am Fam Physician; 2002 Jan; 65(2):217-26. PubMed ID: 11820486
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Trillin, a steroidal saponin isolated from the rhizomes of Dioscorea nipponica, exerts protective effects against hyperlipidemia and oxidative stress.
    Wang T; Choi RC; Li J; Bi CW; Ran W; Chen X; Dong TT; Bi K; Tsim KW
    J Ethnopharmacol; 2012 Jan; 139(1):214-20. PubMed ID: 22100563
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Association of Treatment for Hyperlipidemia with Decreased Total Mortality in Japanese Individuals: the Yamagata (Takahata) Study.
    Daimon M; Oizumi T; Kameda W; Matsui J; Murakami H; Ueno Y; Kubota I; Yamashita H; Kayama T; Kato T
    J Atheroscler Thromb; 2015; 22(10):1030-9. PubMed ID: 26016512
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Drug treatment of hyperlipemia in middle-aged and old persons with ischemic heart disease].
    Semavin IE; Goliakov VN; Solov'ev VV
    Kardiologiia; 1977 Mar; 17(3):77-83. PubMed ID: 196132
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Hypolipidemic and antioxidant activities of sanchi (radix notoginseng) in rats fed with a high fat diet.
    Xia W; Sun C; Zhao Y; Wu L
    Phytomedicine; 2011 Apr; 18(6):516-20. PubMed ID: 21036582
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Update on pediatric hyperlipidemia.
    Chauhan A; Paunikar P
    Curr Opin Pediatr; 2014 Apr; 26(2):252-8. PubMed ID: 24553633
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Regression of coronary atherosclerosis: an achievable goal? Review of results from recent clinical trials.
    Waters D; Lespérance J
    Am J Med; 1991 Jul; 91(1B):10S-17S. PubMed ID: 1867231
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Association of simvastatin and hyperlipidemia with periodontal status and bone metabolism markers.
    Magán-Fernández A; Papay-Ramírez L; Tomás J; Marfil-Álvarez R; Rizzo M; Bravo M; Mesa F
    J Periodontol; 2014 Oct; 85(10):1408-15. PubMed ID: 24555750
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Is the treatment of hyperlipidemia as secondary prevention adequate in different age groups in Israel?
    Shilo L; Feldman J; Gendlman V; Shenkman L; Berner YN
    Isr Med Assoc J; 2003 Jul; 5(7):479-81. PubMed ID: 12901241
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Associations of TSH levels within the reference range with future blood pressure and lipid concentrations: 11-year follow-up of the HUNT study.
    Asvold BO; Bjøro T; Vatten LJ
    Eur J Endocrinol; 2013 Jul; 169(1):73-82. PubMed ID: 23641017
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.